Literature DB >> 6204938

Analysis of the functional epitopes on different HLA-A2 molecules.

E Goulmy, J van der Poel, M Giphart, J J van Rood.   

Abstract

Recent studies show that the serologically defined HLA-A2 molecule can be subdivided according to functional and biochemical characteristics. By the use of various HLA-A2-specific cytotoxic T lymphocytes (CTLs) and isoelectric focusing, the serologically homogeneous HLA-A2 molecule can be divided into four subtypes. The polymorphism of the serologically defined HLA-A2 molecule has also been demonstrated by the use of HLA-A2-restricted CTLs. This study was designed to analyze the functional epitopes on different HLA-A2 molecules with special regard to the recognition patterns of different types of HLA-A2-restricted CTLs directed against minor histocompatibility (minor H) antigens. Fifteen so-called HLA-A2 variants belonging to distinct HLA-A2 subtypes were tested as target cells in the cell-mediated lympholysis (CML) assay against (1) HLA-A2-restricted antiminor H-Y CTLs, (2) HLA-A2 and -B7-restricted antiminor H-Y CTLs, and (3) HLA-A2, -Bw62 and -B27-restricted antiminor "HA" CTLs. We found that those three CTLs recognized only one of those HLA-A2 variants. Furthermore, positive reactions by the antiminor H CTLs were only observed on those variant cells which carried, in addition to the HLA-A2 variant, either another "normal" HLA-A2 molecule or another required restricting class I molecule necessary for associative recognition. These results indicate that the absence of HLA-A2 normal allotypic target determinant(s) leads to the loss of epitope(s) necessary for recognition of minor H-Y and minor "HA" transplantation antigens by HLA-restricted CTLs. We can conclude from the present study that HLA-A2-restricted antiminor H CTLs use, in general, the same epitope (or cluster of epitopes) for cellular recognition as alloimmune HLA-A2-specific CTLs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6204938     DOI: 10.1007/bf00373443

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  23 in total

1.  Y-antigen killing by T cells of women is restricted by HLA.

Authors:  E Goulmy; A Termijtelen; B A Bradley; J J van Rood
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

2.  Recognition of H-2 domains by cytotoxic T lymphocytes.

Authors:  C Weyand; G J Hämmerling; J Goronzy
Journal:  Nature       Date:  1981-08-13       Impact factor: 49.962

3.  Subtypes of HLA-B27 detected by cytotoxic T lymphocytes and their role in self-recognition.

Authors:  M H Breuning; C J Lucas; B S Breur; M Y Engelsma; G G de Lange; A J Dekker; W E Biddison; P Ivanyi
Journal:  Hum Immunol       Date:  1982-12       Impact factor: 2.850

4.  HLA restriction of non-HLA--A, --B, --C and --D cell mediated lympholysis (CML).

Authors:  E Goulmy; A Termijtelen; B A Bradley; J J van Rood
Journal:  Tissue Antigens       Date:  1976-11

5.  Comparative structural analysis of HLA-A2 antigens distinguishable by cytotoxic T lymphocytes: variants M7 and DR1.

Authors:  M S Krangel; S Taketani; W E Biddison; D M Strong; J L Strominger
Journal:  Biochemistry       Date:  1982-11-23       Impact factor: 3.162

6.  Expansion of human lymphocyte populations expressing specific immune reactivities. III. Specific colonies, either cytotoxic or proliferative, obtained from a population of responder cells primed in vitro. Preliminary immunogenetic analysis.

Authors:  B Malissen; D Charmot; C Mawas
Journal:  Hum Immunol       Date:  1981-02       Impact factor: 2.850

7.  In vitro-isolated human cytotoxic T-lymphocyte clones detect variations in serologically defined HLA antigens.

Authors:  H Spits; M Breuning; P Ivanyi; C Russo; J E de Vries
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

8.  Recognition of human minor alloantigen(s) by cytotoxic lymphocytes in vitro.

Authors:  W L Elkins; G Pierson; W Negendank; K S Zier
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

9.  Anti-self HLA may be clonally expressed.

Authors:  E Goulmy; J D Hamilton; B A Bradley
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

10.  In vitro generation of cytotoxic cells specific for human minor histocompatibility antigens by lymphocytes from a normal donor potentially primed during pregnancy.

Authors:  W A Tekolf; S Shaw
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

View more
  4 in total

1.  Molecular analysis of HLA-A2.4 functional variant KLO: close structural and evolutionary relatedness to the HLA-A2.2 subtype.

Authors:  N Doménech; R Castaño; E Goulmy; J A López de Castro
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

2.  Structural analysis of HLA-A2.4 functional variant KNE. Implications for the mapping of HLA-A2-specific T-cell epitopes.

Authors:  N Doménech; A Ezquerra; R Castaño; J A López de Castro
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

3.  Serological and biochemical identification of HLA-Aw33 subtypes.

Authors:  L P de Waal; H J Mesman; C P Engelfriet
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

4.  An HLA-A2 population variant with structural polymorphism in the alpha 3 region.

Authors:  R Castaño; A Ezquerra; N Doménech; J A López de Castro
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.